Development and Validation of Residual Kidney Function Estimating Equations in Dialysis Patients

[1]  B. Kestenbaum,et al.  Proximal Tubular Secretory Clearance: A Neglected Partner of Kidney Function. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[2]  G. Knoll,et al.  Serum BTP concentrations are not affected by hepatic dysfunction , 2018, BMC Nephrology.

[3]  A. Levey,et al.  Measurement and Estimation of Residual Kidney Function in Patients on Dialysis. , 2018, Advances in chronic kidney disease.

[4]  J. Coresh,et al.  Estimated Glomerular Filtration Rate From a Panel of Filtration Markers-Hope for Increased Accuracy Beyond Measured Glomerular Filtration Rate? , 2018, Advances in chronic kidney disease.

[5]  P. Stenvinkel,et al.  Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time , 2017, Kidney and Blood Pressure Research.

[6]  V. Gudnason,et al.  Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  Kamran Shaffi,et al.  Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases , 2017, Front. Med..

[8]  L. Caponi,et al.  β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes , 2017, BMC Nephrology.

[9]  G. Beck,et al.  Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  T. D. Ivanov.  KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update , 2016 .

[11]  Connie M. Rhee,et al.  Residual Kidney Function Decline and Mortality in Incident Hemodialysis Patients. , 2016, Journal of the American Society of Nephrology : JASN.

[12]  J. Coresh,et al.  Estimating residual kidney function in dialysis patients without urine collection. , 2016, Kidney international.

[13]  K. Farrington,et al.  Predicting residual kidney function in hemodialysis patients using serum β-trace protein and β2-microglobulin. , 2016, Kidney international.

[14]  L. Renders,et al.  Comparison of Peritoneal Low-Molecular-Weight-Protein-Removal in CCPD and CAPD Patients Based on C-Terminal Agrin Fragment Clearance , 2016, Kidney and Blood Pressure Research.

[15]  G. Beck,et al.  GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  K. Farrington,et al.  Plasma Levels of Middle Molecules to Estimate Residual Kidney Function in Haemodialysis without Urine Collection , 2015, PloS one.

[17]  T. Wilt,et al.  KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  J. Coresh,et al.  Plasma Iohexol Clearance for Assessing Residual Kidney Function in Dialysis Patients. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  W. van Biesen,et al.  Removal of Different Classes of Uremic Toxins in APD vs CAPD: A Randomized Cross-Over Study , 2015, Peritoneal Dialysis International.

[20]  Martin Krzywinski,et al.  Points of Significance: Sampling distributions and the bootstrap , 2015, Nature Methods.

[21]  S. Huang,et al.  The kinetics of cystatin C removal by hemodialysis. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  M. Adams,et al.  β-Trace protein: a marker of GFR and other biological pathways. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  P. Dahinden,et al.  C-terminal agrin fragment (CAF) as a serum biomarker for residual renal function in peritoneal dialysis patients , 2015, International Urology and Nephrology.

[24]  P. Blake,et al.  Peritoneal Dialysis in China: A Story of Growth and Innovation , 2014, Peritoneal Dialysis International.

[25]  Harold I Feldman,et al.  Estimating glomerular filtration rate from serum creatinine and cystatin C. , 2012, The New England journal of medicine.

[26]  X. Yang,et al.  Is cystatin C a better marker than creatinine for evaluating residual renal function in patients on continuous ambulatory peritoneal dialysis? , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  F. Dekker,et al.  Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  R. Vanholder,et al.  Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  C. Kang,et al.  Application of Cystatin C Reduction Ratio to High-Flux Hemodialysis as an Alternative Indicator of the Clearance of Middle Molecules , 2010 .

[30]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[31]  A. Christensson,et al.  Different elimination patterns of β‐trace protein, β2‐microglobulin and cystatin C in haemodialysis, haemodiafiltration and haemofiltration , 2008, Scandinavian journal of clinical and laboratory investigation.

[32]  T. Sauerbruch,et al.  Serum levels of beta-trace protein and its association to diuresis in haemodialysis patients. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  F. Dekker,et al.  Estimation of residual glomerular filtration rate in dialysis patients from the plasma cystatin C level. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  J. Bargman,et al.  Guideline on Targets for Solute and Fluid Removal in Adult Patients on Chronic Peritoneal Dialysis , 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[35]  A. Testa,et al.  In vivo Removal of High- and Low-Molecular-Weight Compounds in Hemodiafiltration with On-Line Regeneration of Ultrafiltrate , 2006, Nephron Clinical Practice.

[36]  Clinical practice guidelines for peritoneal adequacy, update 2006. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  B. Reiser,et al.  Estimation of the Youden Index and its Associated Cutoff Point , 2005, Biometrical journal. Biometrische Zeitschrift.

[38]  F. Dekker,et al.  Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. , 2004, Journal of the American Society of Nephrology : JASN.

[39]  F. Dekker,et al.  The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD )-2. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  F. Dekker,et al.  Predictors of the rate of decline of residual renal function in incident dialysis patients. , 2002, Kidney international.

[41]  E. Vonesh,et al.  Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. , 2002, Journal of the American Society of Nephrology : JASN.

[42]  D. Churchill,et al.  Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. , 2001, Journal of the American Society of Nephrology : JASN.

[43]  R. Lauwerys,et al.  Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis. , 1995, Kidney international.

[44]  I. Olafsson,et al.  Structure and expression of the human cystatin C gene. , 1990, The Biochemical journal.

[45]  C. Pollock,et al.  Beta-2 Microglobulin Removal during Continuous Ambulatory Peritoneal Dialysis (CAPD) , 1989, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.